Your browser doesn't support javascript.
CO7.1 - Anti-CD20 et severite de la COVID-19 chez les patients vivants avec une sclerose en plaques dans la cohorte COVISEP: un impact different selon la forme progressive ou recurrente-remittente de la sclerose en plaques.
Revue d'Epidemiologie et de Sante Publique ; Conference: EPICLIN 2023 17e Conference francophone d'Epidemiologie Clinique30e Journees des statisticiens des Centres de Lutte contre le Cancer. Paris France. 71(Supplement 2) (no pagination), 2023.
Article in French | EMBASE | ID: covidwho-2315687
ABSTRACT
[Formula presented] [Formula presented] Fig. 1. Impact des anti-CD20 sur le risque de COVID-19 severeCopyright © 2023
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: French Journal: Revue d'Epidemiologie et de Sante Publique Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: French Journal: Revue d'Epidemiologie et de Sante Publique Year: 2023 Document Type: Article